Skip to Content

Viropro Inc VPRO Stock Quote

| Rating as of


Morningstar‘s Stock Analysis VPRO

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics VPRO

Company Profile VPRO

Business Description

Viropro Inc is a biotechnology company operating in the United States. The company is engaged in the sale of technological transfers for biopharmaceutical generic drugs in emerging markets.

4199 Campus Drive, Suite 550
Irvine, CA, 92612
T +1 949 783-6573
Industry Biotechnology
Most Recent Earnings Sep 30, 2011
Fiscal Year End Dec 31, 2012
Employees 34